Bausch Health Companies Inc.
BHC
$7.49
-$0.01-0.13%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.25% | 4.60% | 6.13% | 12.16% | 10.86% |
| Total Other Revenue | 8.33% | 33.33% | 19.23% | 12.00% | 14.29% |
| Total Revenue | 5.29% | 4.92% | 6.27% | 12.15% | 10.89% |
| Cost of Revenue | 6.26% | 9.53% | 3.12% | 11.72% | 10.79% |
| Gross Profit | 4.87% | 2.97% | 7.57% | 12.32% | 10.94% |
| SG&A Expenses | 7.45% | 9.25% | 7.09% | 18.88% | 17.02% |
| Depreciation & Amortization | -5.19% | -6.57% | -8.16% | 8.30% | 0.37% |
| Other Operating Expenses | -66.67% | -- | -- | -- | 200.00% |
| Total Operating Expenses | 4.75% | 5.83% | 3.37% | 12.73% | 10.86% |
| Operating Income | 7.80% | -0.67% | 17.16% | 10.12% | 11.02% |
| Income Before Tax | 191.67% | 31.88% | 3,085.71% | 93.56% | -39.24% |
| Income Tax Expenses | -75.51% | 387.50% | 177.50% | 26.79% | -5.77% |
| Earnings from Continuing Operations | 12,900.00% | -11.69% | 308.51% | 75.92% | -103.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 81.82% | 115.38% | -162.50% | 75.00% | 1,200.00% |
| Net Income | 1,380.00% | 9.38% | 338.46% | 77.51% | -61.54% |
| EBIT | 7.80% | -0.67% | 17.16% | 10.12% | 11.02% |
| EBITDA | 2.97% | -2.75% | 7.78% | 8.93% | 6.47% |
| EPS Basic | 1,366.91% | 10.09% | 327.27% | 77.70% | -61.85% |
| Normalized Basic EPS | -93.21% | 145.30% | 50.78% | 33.67% | 87.17% |
| EPS Diluted | 1,366.91% | 10.09% | 327.27% | 77.70% | -61.14% |
| Normalized Diluted EPS | -93.17% | 145.30% | 50.78% | 33.67% | 87.22% |
| Average Basic Shares Outstanding | 0.82% | 0.76% | 4.92% | 0.82% | 0.85% |
| Average Diluted Shares Outstanding | 0.78% | 0.76% | 4.92% | 0.82% | 0.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |